Taking femoropopliteal excimer laser photoablation therapy to the next level: defining the role of the TURBO-Booster guiding catheter in the CELLO registry.

presented at the International Collegeof Angiology, 51st Annual World Congress;Beijing, China; October 25-28, 2009. 4. Laird J. RESILIENT trial. Available at: http://www.bardpv.com/_vascular/vas-prod-lifestent-resilient.php 5. Shammas NW, Coiner D, Shammas G, et al.Percutaneous lower extremity arterial interven-tions using balloon angioplasty versus SilverHawk atherectomy: results of the SmartHawkrandomized trial [Abstract]. Catheter Cardio-vasc Interv. 2009;73S1:S42. 6. Mongiardo A, Curcio A, Spaccarotella C, et al.Molecular mechanisms of restenosis after per-cutaneous peripheral angioplasty and approach to endovascular therapy. Curr Drug TargetsCardiovasc Haematol Disord. 2004;4:275–287. 7. Scheinert D, Scheinert S, Sax J, et al. Preva-lence and clinical impact of stent fractures afterfemoropopliteal stenting. J Am Coll Cardiol.2005;45:312–315. 8. Tepe G, Zeller T, Albrecht T, et al. Localdelivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med.